Geo News
Community curated by people like you
Latest
AI
Crypto
Health
World Affairs
US Politics
Eli Lilly's Retatrutide Matches Bariatric Surgery: 30% Weight Loss in Phase 3 Trial
Techtimes
View source article
Featured Stories
OpenAI pauses development of Astra AI model over critical cybersecurity capability concerns
Aug 7, 2026
·
2 sources
Eli Lilly's Retatrutide Matches Bariatric Surgery: 30% Weight Loss in Phase 3 Trial — Techtimes
